Evidence map›Paper›PMID 26253634›Full record

ArticleBioorganic & medicinal chemistry letters2015

Synthesis and in vitro evaluation of [18F]FECIMBI-36: A potential agonist PET ligand for 5-HT2A/2C receptors.

Jaya Prabhakaran, Mark D Underwood, J S Dileep Kumar, Norman R Simpson, Suham A Kassir, Mihran J Bakalian, J John Mann, Victoria Arango

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Concise and Scalable Radiosynthesis of (+)-[ACS chemical neuroscience · 2023
    Article
  4. Radiotracers for the Central Serotoninergic System.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  5. Radiosynthesis and Biological Evaluation of [ACS medicinal chemistry letters · 2021
    Article
  6. Article
  7. Article
  8. In vivo PET Imaging of [11C]CIMBI-5, a 5-HT2AR Agonist Radiotracer in Nonhuman Primates.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2019
    Article
  9. Article
  10. In vivo evaluation of [Bioorganic & medicinal chemistry letters · 2017
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jaya PrabhakaranDepartment of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA. Electronic address: jp2155@cumc.columbia.edu.
Mark D UnderwoodMolecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, NY, USA; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA.
J S Dileep KumarMolecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, NY, USA.
Norman R SimpsonMolecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, NY, USA.
Suham A KassirMolecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, NY, USA.
Mihran J BakalianMolecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, NY, USA.
J John MannMolecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, NY, USA; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA.
Victoria ArangoMolecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, NY, USA; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY, USA.
New York State Psychiatric InstituteNew York Psychoanalytic Society and Institute · USColumbia University · US

Funding

Suicidal Behavior: Aggression Subtypes, Childhood Adversity and Stress ResponseP50MH090964 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MANN, JOSEPH JOHN · 2013 to 2022
$23.6M
Evaluation of an [F-18] Agonist PET Ligand for 5HT2ARR21DA041670 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI PRABHAKARAN, JAYA · 2016 to 2017
$459k
Development of agonist PET tracers for quantifying 5HT2ARR21MH091470 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PRABHAKARAN, JAYA · 2011 to 2012
$440k
NIDA NIH HHS R21 DA041670NIMH NIH HHS MH 091470NIMH NIH HHS P50 MH090964NIMH NIH HHS R21 MH091470
6 · The paper itself

Abstract

Radiosynthesis and in vitro evaluation of [(18)F]-2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-(2-fluoroethoxy)benzyl)ethanamine, ([(18)F]FECIMBI-36) or ([(18)F]1), a potential agonist PET imaging agent for 5-HT2A/2C receptors is described. Syntheses of reference standard 1 and the corresponding des-fluoroethyl radiolabeling precursor (2) were achieved with 75% and 65% yields, respectively. In vitro pharmacology assay of FECIMBI-36 by [(3)H]-ketanserin competition binding assay obtained from NIMH-PDSP showed high affinities to 5-HT2AR (Ki = 1nM) and 5-HT2CR (Ki=1.7 nM). Radiolabeling of FECIMBI-36 was achieved from the boc-protected precursor 2 using [(18)F]-fluoroethyltosylate in presence of Cs2CO3 in DMSO followed by removal of the protective group. [(18)F]1 was isolated using RP-HPLC in 25 ± 5% yield, purity > 95% and specific activity 1-2Ci/μmol (N = 6). In vitro autoradiography studies demonstrate that [(18)F]1 selectively label 5-HT2A and 5-HT2C receptors in slide-mounted sections of postmortem human brain using phosphor imaging. Our results indicate the potential of [(18)F]1 for imaging 5-HT2A/2C receptors in the high affinity state in vivo using PET imaging.

Indexed as

Positron-Emission TomographyDose-Response Relationship, DrugEthylaminesFluorine RadioisotopesHumansLigandsMolecular StructureReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2CSerotonin 5-HT2 Receptor AgonistsStructure-Activity Relationship((18)F)-2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-(2-fluoroethoxy)benzyl)ethanamineEthylaminesFluorine RadioisotopesLigandsReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2CSerotonin 5-HT2 Receptor Agonists5-HT5HT(2A/2C)RAgonistPETRadiotracer

Identifiers

PMID26253634
PMCPMC4816213
OpenAlexW1492050170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.